These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 8230452)

  • 21. A poliovirus minireplicon containing an inactive 2A proteinase is expressed in vaccinia virus-infected cells.
    Pal-Ghosh R; Morrow CD
    J Virol; 1993 Aug; 67(8):4621-9. PubMed ID: 8392603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infection.
    Porter DC; Ansardi DC; Choi WS; Morrow CD
    J Virol; 1993 Jul; 67(7):3712-9. PubMed ID: 8389902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mutant poliovirus containing a novel proteolytic cleavage site in VP3 is altered in viral maturation.
    Blair WS; Hwang SS; Ypma-Wong MF; Semler BL
    J Virol; 1990 Apr; 64(4):1784-93. PubMed ID: 2157059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis A virus capsid protein VP1 has a heterogeneous C terminus.
    Graff J; Richards OC; Swiderek KM; Davis MT; Rusnak F; Harmon SA; Jia XY; Summers DF; Ehrenfeld E
    J Virol; 1999 Jul; 73(7):6015-23. PubMed ID: 10364353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Processing determinants required for in vitro cleavage of the poliovirus P1 precursor to capsid proteins.
    Ypma-Wong MF; Semler BL
    J Virol; 1987 Oct; 61(10):3181-9. PubMed ID: 3041039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folding and processing of the capsid protein precursor P1 is kinetically retarded in neutralization site 3B mutants of poliovirus.
    Reynolds C; Birnby D; Chow M
    J Virol; 1992 Mar; 66(3):1641-8. PubMed ID: 1310770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of the RNA binding and protein processing activities of poliovirus polypeptide 3CD by the viral RNA polymerase domain.
    Parsley TB; Cornell CT; Semler BL
    J Biol Chem; 1999 Apr; 274(18):12867-76. PubMed ID: 10212275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system.
    Abrams CC; King AM; Belsham GJ
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():3089-98. PubMed ID: 8847514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Site-specific mutations at a picornavirus VP3/VP1 cleavage site disrupt in vitro processing and assembly of capsid precursors.
    Parks GD; Palmenberg AC
    J Virol; 1987 Dec; 61(12):3680-7. PubMed ID: 2824807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The N-terminal region (VP4) of the foot-and-mouth disease capsid precursor (P1-2A) is not required during its synthesis to allow subsequent processing by the 3C protease.
    Kristensen T; Normann P; Belsham GJ
    Virology; 2022 May; 570():29-34. PubMed ID: 35364457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cleavage site mutations in the encephalomyocarditis virus P3 region lethally abrogate the normal processing cascade.
    Hall DJ; Palmenberg AC
    J Virol; 1996 Sep; 70(9):5954-61. PubMed ID: 8709217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification and characterization of poliovirus polypeptide 3CD, a proteinase and a precursor for RNA polymerase.
    Harris KS; Reddigari SR; Nicklin MJ; Hämmerle T; Wimmer E
    J Virol; 1992 Dec; 66(12):7481-9. PubMed ID: 1331532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of poliovirus P3 proteins using a recombinant vaccinia virus results in proteolytically active 3CD precursor protein without further processing to 3Cpro and 3Dpol.
    Porter DC; Ansardi DC; Lentz MR; Morrow CD
    Virus Res; 1993 Sep; 29(3):241-54. PubMed ID: 8237109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of the VP1/2A junction cleavage by the 3C protease in foot-and-mouth disease virus-infected cells.
    Kristensen T; Normann P; Gullberg M; Fahnøe U; Polacek C; Rasmussen TB; Belsham GJ
    J Gen Virol; 2017 Mar; 98(3):385-395. PubMed ID: 27902359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conditional poliovirus mutants made by random deletion mutagenesis of infectious cDNA.
    Kirkegaard K; Nelsen B
    J Virol; 1990 Jan; 64(1):185-94. PubMed ID: 2152811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification of enzymatically active poliovirus proteinase 3C produced in Escherichia coli.
    Takahara Y; Ando N; Kohara M; Hagino-Yamagishi K; Nomoto A; Itoh H; Numao N; Kondo K
    Gene; 1989 Jul; 79(2):249-58. PubMed ID: 2551776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allele-specific adaptation of poliovirus VP1 B-C loop variants to mutant cell receptors.
    Liao S; Racaniello V
    J Virol; 1997 Dec; 71(12):9770-7. PubMed ID: 9371643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Single Amino Acid Substitution in Poliovirus Nonstructural Protein 2CATPase Causes Conditional Defects in Encapsidation and Uncoating.
    Asare E; Mugavero J; Jiang P; Wimmer E; Paul AV
    J Virol; 2016 Jul; 90(14):6174-6186. PubMed ID: 27076638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural domains of the poliovirus polyprotein are major determinants for proteolytic cleavage at Gln-Gly pairs.
    Ypma-Wong MF; Filman DJ; Hogle JM; Semler BL
    J Biol Chem; 1988 Nov; 263(33):17846-56. PubMed ID: 2846581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein.
    Toyoda H; Nicklin MJ; Murray MG; Anderson CW; Dunn JJ; Studier FW; Wimmer E
    Cell; 1986 Jun; 45(5):761-70. PubMed ID: 3011278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.